Literature Collection

Collection Insights

11K+

References

9K+

Articles

1400+

Grey Literature

4600+

Opioids & SU

The Literature Collection contains over 11,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Year
Sort by
Order
Show
11236 Results
22
"Cocaine Bugs": Implications for Primary Care Providers
Type: Journal Article
Authors: J. Torales, J. Almirón-Santacruz, I. Barrios, M. O'Higgins, O. Melgarejo, R. Navarro, I. González, M. Jafferany, J. M. Castaldelli-Maia, A. Ventriglio
Year: 2022
Publication Place: United States
Topic(s):
Education & Workforce See topic collection
,
Opioids & Substance Use See topic collection
24
"Come try it out. Get your foot in the door:" Exploring patient perspectives on low-barrier treatment for opioid use disorder
Type: Journal Article
Authors: Margaret Lowenstein, Matthew P. Abrams, Molly Crowe, Kelsey Shimamoto, Silvana Mazzella, Denise Botcheos, Jennifer Bertocchi, Shawn Westfahl, Judy Chertok, Kristine Pamela Garcia, Rachael Truchil, M. Holliday-Davis, Shoshana Aronowitz
Year: 2023
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
27
"COVID just kind of opened a can of whoop-ass": The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada
Type: Journal Article
Authors: Stephanie Glegg, Karen McCrae, Gillian Kolla, Natasha Touesnard, Jeffrey Turnbull, Thomas D. Brothers, Rupinder Brar, Christy Sutherland, Bernard Le Foll, Andrea Sereda, Marie-Ève Goyer, Nanky Rai, Scott Bernstein, Nadia Fairbairn
Year: 2022
Topic(s):
Education & Workforce See topic collection
28
"Did I Do as Best as the System Would Let Me?" Healthcare Professional Views on Hospital to Home Care Transitions
Type: Journal Article
Authors: Melinda M. Davis, Meg Devoe, Devan Kansagara, Christina Nicolaidis, Honora Englander
Year: 2012
Topic(s):
Key & Foundational See topic collection
29
"Dying is Not a Fear": Teen and Parent Perspectives on Messaging to Prevent Crystal Meth Use Among Teens in Rural North Idaho
Type: Journal Article
Authors: M. R. Skeer, D. M. Landy, J. M. Abrahams, J. Towers
Year: 2021
Publication Place: United States
Abstract:

Crystal methamphetamine ("meth") use is on the rise in the USA, having devastating effects on individuals and communities. Innovative prevention strategies are therefore critical. Through an exploratory qualitative study, we examined the perspectives and experiences of teenagers and parents around meth prevention messaging formats and strategies. Teens and adults were recruited through middle and high schools, libraries, local sporting events, and word of mouth in three communities in North Idaho, May-September 2016. Guided by the theoretical framework of the Extended Parallel Process Model, we conducted focus groups and small group interviews (three teen; two adults). Using a deductive content analytic approach, we developed teen- and adult-specific codebooks, analyzed the transcripts with NVivo 12-Plus, and identified themes. Teens and adults were all acutely aware of meth use in their communities, personally knowing people who were addicted to meth, and all understood the oral ("meth mouth") and physical ("crank bugs") consequences of meth use. Three primary themes were identified, which focused on the effects of, addiction to, and messaging around crystal meth use. For teens and adults, images illustrating the effects of meth were least effective if they appeared unrealistic or comical. Teens resonated most with messages focusing on pain and vanity (bad teeth and breath), and there was consensus that showing teens images simulating changes in their appearance over time as a result of meth use in a clinical setting would be an effective prevention strategy. Teens and adults who had exposure to meth addiction in North Idaho felt that prevention messages focused on meth are imperative, given its high prevalence and deleterious effects. Future work will entail developing and testing a communication-based meth prevention strategy along with tailored messaging that can be used with teens in dental settings.

Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
31
"Get in and get out, get on with life": Patient and provider perspectives on methadone van implementation for opioid use disorder treatment
Type: Journal Article
Authors: L. W. Suen, S. Steiger, B. Shapiro, S. Castellanos, N. Joshi, B. H. Lambdin, K. R. Knight
Year: 2023
Topic(s):
Opioids & Substance Use See topic collection
32
"Guide to Equity for Medicare–Medicaid Enrollees (Dual Enrollees)"
Type: Government Report
Authors: Eva H. Allen, Kimá J. Taylor, Taylor Nelson, Sofia Hinojosa
Year: 2023
Publication Place: Washington, DC
Topic(s):
Healthcare Policy See topic collection
,
Financing & Sustainability See topic collection
,
Healthcare Disparities See topic collection
,
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

33
"Hub and Spoke:" Vermont's Framework for Medication Assisted Treatment for Opioid Addiction
Type: Web Resource
Authors: Beth Tanzman, Anthony Folland
Year: 2016
Abstract:

Webinar - Faced with increasing rates of opioid addiction and insufficient treatment capacity to meet demand for care, Vermont developed a novel framework to expand medication assisted treatment in both Opioid Treatment Programs (OTPs) and Office-Based Opioid Treatment (OBOT) settings. Although this initiative initially focuses on medication assisted treatment for individuals with opioid use disorders, it creates a framework for integrating treatment services for other substance abuse issues and co-occurring mental health disorders into the medical home through a managed approach to care. In addition, this treatment approach will help reduce recidivism in corrections and enhance outcomes for families where addiction is an identified problem for child welfare. Note: Viewing of the webinar requires free registration.

Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
,
Medical Home See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

34
"I am not a junkie": Social categorization and differentiation among people who use drugs
Type: Journal Article
Authors: A. L. Sibley, R. Baker, X. A. Levander, A. Rains, S. M. Walters, K. Nolte, D. C. Colston, H. M. Piscalko, C. A. Schalkoff, E. Bianchet, S. Chen, P. Dowd, M. Jaeb, P. D. Friedmann, R. J. Fredericksen, D. W. Seal, V. F. Go
Year: 2023
Topic(s):
Opioids & Substance Use See topic collection
35
"I didn't feel like a number": The impact of nurse care managers on the provision of buprenorphine treatment in primary care settings
Type: Journal Article
Authors: N. Beharie, M. Kaplan-Dobbs, A. Urmanche, D. Paone, A. Harocopos
Year: 2022
Publication Place: United States
Abstract:

BACKGROUND AND OBJECTIVE: To promote increased access to and retention in buprenorphine treatment for opioid use disorder, the New York City (NYC) Department of Health and Mental Hygiene (DOHMH) implemented the Buprenorphine Nurse Care Manager Initiative (BNCMI) in 2016, in which nurse care managers (NCMs) coordinate buprenorphine treatment in safety-net primary care clinics. To explore how patients experienced the care they received from NCMs, DOHMH staff conducted in-person, in-depth interviews with patients who had, or were currently receiving, buprenorphine treatment at BNCMI clinics. Participants were patients who were receiving, or had received, buprenorphine treatment through BNCMI at one of the participating safety-net primary care practices. METHODS: The study team used a thematic analytic and framework analysis approach to capture concepts related to patient experiences of care received from NCMs, and to explore differences between those who were in treatment for at least six consecutive months and those who left treatment within the first six months. RESULTS: Themes common to both groups were that NCMs showed care and concern for patients' overall well-being in a nonjudgmental manner. In addition, NCMs provided critical clinical and logistical support. Among out-of-treatment participants, interactions with the NCM were rarely the catalyst for disengaging with treatment. Moreover, in-treatment participants perceived the NCM as part of a larger clinical team that collectively offered support, and the care provided by NCMs was often a motivating factor for them to remain engaged in treatment. CONCLUSION: Findings suggest that by providing emotional, clinical, and logistical support, as well as intensive engagement (e.g., frequent phone calls), the care that NCMs provide could encourage retention of patients in buprenorphine treatment.

Topic(s):
Education & Workforce See topic collection
,
Opioids & Substance Use See topic collection
36
"I didn't want to be on Suboxone at first…" - Ambivalence in Perinatal Substance Use Treatment
Type: Journal Article
Authors: B. Ostrach, C. Leiner
Year: 2019
Publication Place: United States
Abstract:

OBJECTIVES: The objectives of this article are to present findings from recent qualitative research with patients in a combined perinatal substance use treatment program in Central Appalachia, and to describe and analyze participants' ambivalence about medication-assisted treatment for opioid use disorder (OUD), in the context of widespread societal stigma and judgement. METHODS: We conducted research in a comprehensive outpatient perinatal substance use treatment program housed in a larger obstetric practice serving a large rural, Central Appalachian region. The program serves patients across the spectrum of substance use disorders but specifically offers medication-assisted treatment to perinatal patients with OUD. We purposively and opportunistically sampled patients receiving prescriptions for buprenorphine or buprenorphine-naloxone dual product, along with prenatal care and other services. Through participant-observation and semi-structured interviews, we gathered qualitative data from 27 participants, in a total of 31 interviews. We analyzed transcripts of interviews and fieldnotes using modified Grounded Theory. RESULTS: Participants in a combined perinatal substance use treatment program value supportive, non-judgmental care but report ambivalence about medication, within structural and institutional contexts of criminalized, stigmatized substance use and close scrutiny of their pregnancies. Women are keenly aware of the social and public consequences for themselves and their parenting, if they begin or continue medication treatment for OUD. CONCLUSIONS: Substance use treatment providers should consider the social consequences of medication treatment, as well as the clinical benefits, when presenting treatment options and recommendations to patients. Patient-centered care must include an understanding of larger social and structural contexts.

Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
37
"I don't think of it as a shelter. I say I'm going home": a qualitative evaluation of a low-threshold shelter for women who use drugs
Type: Journal Article
Authors: C. A. Beaugard, F. Khudairi, O. Yesufu, A. Farina, J. Laks
Year: 2024
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
,
Education & Workforce See topic collection
38
"I don't want to die": a qualitative study of coping strategies to prevent fentanyl-related overdose deaths among people who inject drugs and its implications for harm reduction policies
Type: Journal Article
Authors: R. Abadie
Year: 2023
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
39
"I go out of my way to give them an extra smile now:" A study of pharmacists who participated in Respond to Prevent, a community pharmacy intervention to accelerate provision of harm reduction materials
Type: Journal Article
Authors: A. N. Irwin, M. Gray, D. Ventricelli, J. S. Boggis, J. Bratberg, A. S. Floyd, J. Silcox, D. M. Hartung, T. C. Green
Year: 2024
Topic(s):
Opioids & Substance Use See topic collection
,
Education & Workforce See topic collection
40
"I'm Clean and Sober, But Not Necessarily Free": Perceptions of Buprenorphine Among Patients in Long-Term Treatment
Type: Journal Article
Authors: J. J. Wyse, T. I. Lovejoy, A. J. Gordon, K. Mackey, A. Herreid-O'Neill, B. J. Morasco
Year: 2023
Abstract:

BACKGROUND: Patients receiving buprenorphine for the treatment of opioid use disorder (OUD) experience a roughly 50% reduction in mortality risk relative to those not receiving medication. Longer periods of treatment are also associated with improved clinical outcomes. Despite this, patients often express desires to discontinue treatment and some view taper as treatment success. Little is known about the beliefs and medication perspectives of patients engaged in long-term buprenorphine treatment that may underlie motivations to discontinue. METHODS: This study was conducted at the VA Portland Health Care System (2019-2020). Qualitative interviews were conducted with participants prescribed buprenorphine for ≥2 years. Coding and analysis were guided by directed qualitative content analysis. RESULTS: Fourteen patients engaged in office-based buprenorphine treatment completed interviews. While patients expressed strong enthusiasm for buprenorphine as a medication, the majority expressed the desire to discontinue, including patients actively tapering. Motivations to discontinue fell into 4 categories. First, patients were troubled by perceived side effects of the medication, including effects on sleep, emotion, and memory. Second, patients expressed unhappiness with being "dependent" on buprenorphine, framed in opposition to personal strength/independence. Third, patients expressed stigmatized beliefs about buprenorphine, describing it as "illicit," and associated with past drug use. Finally, patients expressed fears about buprenorphine unknowns, including potential long-term health effects and interactions with medications required for surgery. CONCLUSIONS: Despite recognizing benefits, many patients engaged in long-term buprenorphine treatment express a desire to discontinue. Findings from this study may help clinicians anticipate patient concerns and can be used to inform shared decision-making conversations regarding buprenorphine treatment duration.

Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection